Novartis, Pfizer seek U.S. approval of meningitis vaccines
June 17, 2014 at 10:40 AM EDT
June 17 (Reuters) - Pfizer Inc and rival Swiss drugmaker Novartis AG on Tuesday said they had asked U.S. regulators to approve their vaccines to prevent meningitis infections in people aged 10 to 25.